HC Wainwright & Co. Reiterates Buy on Neurocrine Biosciences, Maintains $150 Price Target

Moomoo 24/7 ·  Apr 24 06:05

HC Wainwright & Co. analyst Andrew Fein reiterates Neurocrine Biosciences (NASDAQ:NBIX) with a Buy and maintains $150 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment